ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
124.610,41
-2,40%
S&P 500
5.998,74
-0,38%
US Dollar vs BRL
6,0152
0,00%
Bitcoin
95.576,57
-0,08%
Brent Oil
72,675
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Momenta Pharmaceuticals Inc (MNTA)

  7. Momenta Pharmaceuticals Inc (MNTA) Notícias

MNTA

Momenta Pharmaceuticals (MNTA)

Momenta Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:MNTA
DataHoraFonteTítuloCódigoCompanhia
10/11/202012:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
13/10/202009:15Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202018:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202017:55Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202017:31Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202017:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202010:55Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202010:00Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202009:57Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
01/10/202009:44GlobeNewswire Inc.Momenta Pharmaceuticals Announces Completion of Proposed Sale to Johnson & JohnsonNASDAQ:MNTAMomenta Pharmaceuticals Inc
25/09/202018:47PR Newswire (US)Chesapeake Utilities to Join S&P SmallCap 600NASDAQ:MNTAMomenta Pharmaceuticals Inc
15/09/202009:00GlobeNewswire Inc.Momenta Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period in Connection with Proposed Sale to Johnson ...NASDAQ:MNTAMomenta Pharmaceuticals Inc
02/09/202007:54Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:MNTAMomenta Pharmaceuticals Inc
20/08/202016:18Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:MNTAMomenta Pharmaceuticals Inc
20/08/202004:02Dow Jones NewsJ&J, Biotech Firm In $6.5 Billion Deal J&J Agrees to Buy Biotech Company -- WSJNASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202017:26Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202008:21Dow Jones NewsJohnson & Johnson to Buy Momenta Pharmaceuticals for $6.5 BillionNASDAQ:MNTAMomenta Pharmaceuticals Inc
19/08/202007:35GlobeNewswire Inc.Momenta Enters Definitive Agreement with Johnson & JohnsonNASDAQ:MNTAMomenta Pharmaceuticals Inc
10/08/202017:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:MNTAMomenta Pharmaceuticals Inc
10/08/202008:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports Second Quarter 2020 Financial and Operating ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
03/08/202008:30GlobeNewswire Inc.Momenta Pharmaceuticals Announces Date of Second Quarter 2020 Financial Results Conference Call and WebcastNASDAQ:MNTAMomenta Pharmaceuticals Inc
28/07/202008:15GlobeNewswire Inc.Momenta Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Nipocalimab in HDFNNASDAQ:MNTAMomenta Pharmaceuticals Inc
15/06/202008:05GlobeNewswire Inc.Momenta Pharmaceuticals Announces Positive Topline Data from Interim Analysis of Phase 2 Vivacity-MG Study of Nipocalimab (M2...NASDAQ:MNTAMomenta Pharmaceuticals Inc
07/05/202008:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports First Quarter 2020 Financial and Operating ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
06/05/202011:04Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:MNTAMomenta Pharmaceuticals Inc
24/04/202018:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MNTAMomenta Pharmaceuticals Inc
23/04/202009:00GlobeNewswire Inc.Momenta Pharmaceuticals Announces Date of First Quarter 2020 Financial Results Conference Call and WebcastNASDAQ:MNTAMomenta Pharmaceuticals Inc
02/04/202008:30GlobeNewswire Inc.Momenta Provides Corporate Update Amid COVID-19 PandemicNASDAQ:MNTAMomenta Pharmaceuticals Inc
27/02/202018:35Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MNTAMomenta Pharmaceuticals Inc
26/02/202009:00GlobeNewswire Inc.Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial ResultsNASDAQ:MNTAMomenta Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:MNTA

Seu Histórico Recente

BOV
GFSA3
GAFISA ON
BOV
ATOM3
ATOMPAR ON
BOV
RNEW4
RENOVA PN
BOV
IBOV
Índice Bovespa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Economize até 60%* para TRADER PLUS

1 ano 40%, 2 anos 50% e *3 anos 60%

*Ao longo de 3 anos $ 1475.65 apenas $ 590.25